Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2008
12/11/2008US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
12/11/2008US20080305988 V-Like Domain Binding Molecules
12/11/2008US20080305961 Method of Generating Translationally Active Linear Dna Molecules and Use Thereof in Array Formats
12/11/2008US20080305957 Method for Obtaining Structural Information Concerning an Encoded Molecule and Method for Selecting Compounds
12/11/2008US20080305547 Method for enhanced functional expression of cell receptors
12/11/2008US20080305543 RNA interference pathway genes as tools for targeted genetic interference
12/11/2008US20080305542 G protein coupled receptor (GPCR) polypeptide, attached to a detectable label seleacted from green fluorescent polypeptide or a rhodopsin polypeptide, involved in bitter taste transduction; used as additives for foods, beverages and drugs in order to modify T2R-associated bitter taste
12/11/2008US20080305541 Recombinant vectors for use in position-independent transgene expression within chromatin
12/11/2008US20080305535 In vitro amplification of nucleic acid molecules via circular replicons
12/11/2008US20080305534 Novel Glycerol Dehydrogenase, Gene Therefor, and Method of Utilizing the Same
12/11/2008US20080305532 Gene For Coenzyme Pqq Synthesis Protein B From Gluconobacter Oxydans
12/11/2008US20080305528 Isolation of nucleic acids
12/11/2008US20080305527 Single Chain Pan ECTO-NOX Variable Region (ScFv) Antibody, Coding Sequence and Methods
12/11/2008US20080305526 Melibiose Operon Expression System
12/11/2008US20080305525 production system for a recombinant glycoprotein having therapeutic value in humans using a methylotrophic, thermotolerant yeast; host system for mass production of recombinant hepatitis vaccines
12/11/2008US20080305523 Fungal Promoter for Expressing a Gene in a Fungal Cell
12/11/2008US20080305522 Novel Taste-Modifying Polypeptide Nas, Dna Thereof and Use Thereof
12/11/2008US20080305521 Method for Overproducing Specific Recombinant Protein with P. Cinnabarinus Monokaryotic Strains
12/11/2008US20080305520 Mechanosensitive ion channels and methods of use
12/11/2008US20080305490 Amplification of human mdm2 gene in human tumors
12/11/2008US20080305483 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
12/11/2008US20080305480 Novel tumor marker
12/11/2008US20080305471 polypeptides comprising an amino acid sequence of a photocatalytic unit of a photosynthetic microorganism, capable of maintaining photocatalytic activity when attached to solid surfaces of electrooptic devices
12/11/2008US20080305157 Encapsulation and separation of charged organic solutes inside catanionic vesicles
12/11/2008US20080305131 Cancer Immunotherapy with Semi-Allogeneic Cells
12/11/2008US20080305125 Mutant Forms Of EtxB and CtxB And Their Use As Carriers
12/11/2008US20080305124 Oral pertussis vaccine and method for producing pertussis vaccine
12/11/2008US20080305122 Ii-Key/antigenic epitope hybrid peptide vaccines
12/11/2008US20080305121 Agents for Regulating the Activity of Interferon-Producing Cells
12/11/2008US20080305119 Modified Bacteriophage Vectors and Uses Thereof
12/11/2008US20080305117 Kir-Binding Agents and Methods of Use Thereof
12/11/2008US20080305116 Anti-Cd154 Antibodies
12/11/2008US20080305112 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient
12/11/2008US20080305111 Anti-C35 antibodies for treating cancer
12/11/2008US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof
12/11/2008US20080305109 Method of passive immunization
12/11/2008US20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto
12/11/2008US20080305105 Bispecific antibodies
12/11/2008US20080305099 degrades soluble and insoluble A beta so that it can prevent the accumulation of A beta in brain or reduce the accumulation; Alzheimer's disease and Down's syndrome
12/11/2008US20080305098 Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor
12/11/2008US20080305091 Poly-Epitope Peptide Derived from Thymidylate Synthase Having Immunological and Anti-Tumour Activity
12/11/2008US20080305088 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
12/11/2008US20080305084 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
12/11/2008US20080305083 Gfap-based gene therapy for treatment of retinal diseases
12/11/2008US20080305080 Recombinant super-compound interferon
12/11/2008US20080305078 Soluble Il-17Rc Variant and Uses Thereof
12/11/2008US20080305074 Stem cell factor
12/11/2008US20080302662 Method And Apparatus Of Concentration And Purification Of Nucleic Acid
12/11/2008DE102008024282A1 Verfahren zur Vorhersage der Sekundärstruktur einer Nucleinsäuresequenz, Vorhersagevorrichtung für die Sekundärstruktur einer Nucleinsäuresequenz und Vorhersageprogramm zum Vorhersagen der Sekundärstruktur einer Nucleinsäuresequenz Method for predicting the secondary structure of a nucleic acid sequence predictor for secondary structure of nucleic acid sequence and prediction program for predicting the secondary structure of nucleic acid sequence
12/11/2008DE102007005192A1 Producing a peptide for triggering an autoimmune response in a vertebrate comprises preparing a peptide comprising at least one consensus sequence between between similar microbial and vertebrate sequences
12/11/2008CA2857507A1 Use of genetically modified organisms to generate biomass degrading enzymes
12/11/2008CA2725953A1 Methods for production and uses of multipotent cell populations, pluripotent cell populations, neuronal cell populations, and muscle cell populations
12/11/2008CA2724432A1 Compositions and methods for binding lysophosphatidic acid
12/11/2008CA2700061A1 Hcv ns3 replicon shuttle vectors
12/11/2008CA2693525A1 Nanocarrier based plant transfection and transduction
12/11/2008CA2691617A1 Reduction of off-target rna interference toxicity
12/11/2008CA2690855A1 Resistance to abiotic stress in plants
12/11/2008CA2690188A1 Suppression of resistance in insects to bacillus thuringiensis cry toxins, using toxins that do not require the cadherin receptor
12/11/2008CA2690113A1 A screening method for compounds that reduce er stress
12/11/2008CA2689988A1 Methods for producing human ceramide using yeast transformants
12/11/2008CA2689972A1 Method of preparing a dough-based product
12/11/2008CA2689923A1 Nucleic acid functionalized nanoparticles for therapeutic applications
12/11/2008CA2689591A1 Method of expanding human hepatocytes in vivo
12/11/2008CA2689556A1 Expression of soluble antibody fragment by truncation of ch1 domain
12/11/2008CA2689537A1 Epigenetic methods
12/11/2008CA2689345A1 Methods and means for exact replacement of target dna in eukaryotic organisms
12/11/2008CA2689317A1 Antigen presenting cells
12/11/2008CA2689302A1 Clostridial toxin netb
12/11/2008CA2689272A1 Novel plant virus designated tomato marchitez virus
12/11/2008CA2689145A1 Pressure-enhanced extraction and partitioning of molecules
12/11/2008CA2689134A1 Yield enhancement in plants by modulation of maize mads box transcription factor zmm28
12/11/2008CA2689124A1 T-cell cytokine-inducing surface molecules and methods of use
12/11/2008CA2689120A1 Targeted induction of aggregation of proteins with cross beta structures
12/11/2008CA2688834A1 Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies
12/11/2008CA2688682A1 Cytochrome p450 genes conferring herbicide resistance
12/11/2008CA2688678A1 Fhl1 mutations associated with novel x-linked muscular myopathies
12/11/2008CA2688491A1 Water soluble crosslinked polymers
12/11/2008CA2688481A1 Yield enhancement in plants by modulation of maize mads box transcription factor silky1
12/11/2008CA2687921A1 Mammalian expression vector with a highly efficient secretory signal sequence
12/11/2008CA2687888A1 Sequences and methods for detecting influenza a and influenza b virus
12/11/2008CA2687866A1 Anti-notch1 nrr antibodies and methods using same
12/11/2008CA2687538A1 The puro-dhfr quadrifunctional marker and its use in protein production
12/11/2008CA2687171A1 Amplification method of methylated or unmethylated nucleic acid
12/11/2008CA2685594A1 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
12/11/2008CA2681183A1 Raccoon poxvirus expressing genes of feline antigens
12/10/2008EP2000804A2 Direct screening method
12/10/2008EP2000546A1 Core export reporter system
12/10/2008EP2000545A1 Compositions and methods for the diagnosis and treatment of tumor
12/10/2008EP2000541A1 Humanized anti-cd20 monoclonal antibody
12/10/2008EP2000539A1 Resistance to abiotic stress in plants
12/10/2008EP2000538A2 Plant artificial chromosome (PLAC) compositions and methods for using them
12/10/2008EP2000537A2 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
12/10/2008EP2000536A2 Tat-derived transport polypeptides
12/10/2008EP2000535A1 Circovirus sequences associated with porcine wasting disease (PWD)
12/10/2008EP2000534A2 Nucleic acid ligands of tissue target related applications
12/10/2008EP2000533A2 Isolation and purification of nucleic acids
12/10/2008EP2000532A1 Methods of measuring human cytochrome P450 (CYP2C8/9)
12/10/2008EP2000531A1 Antigen presenting cells
12/10/2008EP2000483A2 Vegf receptor fusion protein and use thereof
12/10/2008EP2000482A1 Compositions and methods for the diagnosis and treatment of tumor